Clinical Trial Update: A Study of BEBT-209 Plus Chemotherapy in Patients With Locally Advanced or Metastatic Triple-Negative Breast Cancer [Phase 2, Phase 3]

View source ↗

Summary

Clinical Trial Update for BEBT-209 in combination with chemotherapy for Locally Advanced Triple-negative Breast Cancer or Metastatic Triple-negative Breast Canc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Triple-negative Breast Cancer

Drugs mentioned

• BEBT-209

Snippet

Sponsor: BeBetter Med Inc | Conditions: Locally Advanced Triple-negative Breast Cancer, Metastatic Triple-negative Breast Cancer | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING